0021

Jiangsu Aoyang Health Industryltd Stock Price

Symbol: SZSE:002172Market Cap: CN¥3.1bCategory: Materials

002172 Share Price Performance

Community Fair Values

    Recent 002172 News & Updates

    No updates

    Jiangsu Aoyang Health Industry Co.ltd. Key Details

    CN¥1.9b

    Revenue

    CN¥1.6b

    Cost of Revenue

    CN¥252.8m

    Gross Profit

    CN¥224.5m

    Other Expenses

    CN¥28.3m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    Aug 27, 2025
    Earnings per share (EPS)
    0.037
    Gross Margin
    13.44%
    Net Profit Margin
    1.51%
    Debt/Equity Ratio
    672.6%

    Jiangsu Aoyang Health Industry Co.ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 002172

    Founded
    2001
    Employees
    2224
    CEO
    Jing Li
    WebsiteView website
    www.ayjk.cn

    Jiangsu Aoyang Health Industry Co.ltd. engages in the production and sale of chemical fibers in China and internationally. It engages in the investment and development in the health industry; manufacture and sale of viscose fiber and viscose fiber products, degradable fibers, and functional fibers; sale of textile raw materials, textiles, and chemical products; steam heat supply; power production; and self-operated and agency of the import and export of commodities and technologies. In addition, it offers health management and pharmaceutical logistics, as well as distributes pharmaceutical products. The company was formerly known as Jiangsu Aoyang Technology Corporation Limited. and changed its name to Jiangsu Aoyang Health Industry Co.ltd. in September 2018. Jiangsu Aoyang Health Industry Co.ltd. was incorporated in 2001 and is based in Zhangjiagang, China.

    Chinese Market Performance

    • 7 Days: -1.1%
    • 3 Months: 10.9%
    • 1 Year: 30.1%
    • Year to Date: 11.3%
    Over the last 7 days, the market has dropped 1.1%, driven by a pullback of 1.9% in the Industrials sector. In the last year, the market is actually up 30%. Looking forward, earnings are forecast to grow by 24% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading